Cancer treatment in the United States is more expensive than in other developed countries but achieves better outcomes, a new study has shown. The study looked at survival after cancer diagnosis in the US and 10 European Union countries and "looked at the value of any additional gains [in ...
Xu X, et al. Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review. Transl Cancer Res 2022;11(1):276-287. doi: 10.21037/tcr-20-3539 Sun Q, et al. (2014) Discovery of fruquintinib, a...
Variation in biosimilar uptake in Europe. JAMA Intern Med. 2021;181(3):403-404. doi:10.1001/jamainternmed.2020.6567 ArticlePubMedGoogle ScholarCrossref 86. Jensen TB, Kim SC, Jimenez-Solem E, Bartels D, Christensen HR, Andersen JT. Shift from adalimumab ...
Their hope is that the treatment they get in the casino-hospital will make them well again – CURED! That’s the gamble they are taking. All gamblers know that they cannot win all the time. In fact, you lose more often than you win in this cancer game. Let us examine the reality of...
Second-line treatment options for patients with relapsed, extensive-stage small cell lung cancer (ES-SCLC) are limited, and even with currently available t
Analysis of launch and postapproval cancer drug pricing, clinical benefit, and policy implications in the US and Europe. JAMA Oncol. 2021;7(9):e212026. doi:10.1001/jamaoncol.2021.2026 ArticlePubMedGoogle ScholarCrossref 17. Gordon N, Stemmer SM, Greenberg D, Goldstein DA...
in developed regions of the world, such as North America and Europe, than in countries in impoverished regions, such as certain areas of Asia and Africa. However, differences in breast cancer incidence anddeath ratebetween developed and developing regions are due primarily to differences in the ...
Maude Hebert University of Quebec in Trois-Rivieres, Canada View More Recommended Global Oncology & Cancer Webinars & Conferences Europe & UK Pharma Europe 2025, Italy Antibiotics 2025, France Infectious Diseases 2025, France Eurobiosimilars 2025, France Asia Pacific & Middle East Public Health 20...
The incidence of cancer in the United Kingdom has increased significantly over the last four decades. The aim of this study was to examine trends in UK cancer incidence and mortality by cancer site and assess the potential for overdiagnosis. Using Cancer Research UK incidence and mortality data ...
7 The FDA accelerated approval program has implications for other health care systems, as new drugs often enter the US market first.8 In Europe, decisions from the European Medicines Agency (EMA) closely align with those of the FDA, and the EMA typically relies on the same set of clinical ...